Materials and methods Antibodies Antibodies against GLUD1 (Proteintech, #14299-1-AP), PRMT7 (ABclonal, #A17164), AKT1 (Cell Signaling Technology, #4691), SYVN1 (Epizyme Biotech, # R015002), STUB1 (Epizyme Biotech, #R015148), Vinculin (Proteintech, #26520-1-AP), Mono-methyl arginine (Cell Signaling Technology, #8015), Pan phospho-Tyr (ABclonal, #AP1316), Flag-HRP (Proteintech, #HRP-66008), GFP (ABclonal, #AE078), HA-HRP (Proteintech, #HRP-81290), Ubiquitin-HRP (Cell Signaling Technology, #14049) were purchased commercially
Around 10% of the 66 million Medicare beneficiaries are expected to be eligible for the drugs starting next year with new, expanded access
Get started with a better you, today!
Q., da Silva, L
a number of the agonists in Table 1 (Families 2-5) have norleucine at Rj, or an amino acid residue a number of an amino acid residues (D or L) may be used at residue Ri, including without limitation, tyrosine, phenylalanine, aspartic acid, arginine, isoleucme, serine, histidine, glycine, cysteine, methionine, tryptophan, norvaline, ornithine, S-benzyl cysteine amino acid residues
